Ezh2 mutations were also shown to cooperate with deregulated BCL6 expression in a compound IμHABCL6;Ezh2 knock-in mouse model, giving rise to a transplantable, GC-derived DLBCL-like disease. Here, EZH2 is linked to diffuse large B-cell lymphoma.